High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil

Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a determining factor for AIDS diagnosis. The growing geographical overlap of HIV-1 and infections is an emerging challenge worldwide, as co-infection increases morbidity and mortality for both infection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in microbiology 2023-07, Vol.14, p.1221682-1221682
Hauptverfasser: de Moraes, Laise, Santos, Luciane Amorim, Arruda, Liã Bárbara, da Silva, Maria da Purificação Pereira, Silva, Márcio de Oliveira, Silva, José Adriano Góes, Ramos, André, Dos Santos, Marcos Bastos, Torres, Felipe Guimarães, Orge, Cibele, Teixeira, Antonio Marcos Dos Santos, Vieira, Thiago Santos, Ramírez, Laura, Soto, Manuel, Grassi, Maria Fernanda Rios, de Siqueira, Isadora Cristina, Costa, Dorcas Lamounier, Costa, Carlos Henrique Nery, Andrade, Bruno de Bezerril, Akrami, Kevan, de Oliveira, Camila Indiani, Boaventura, Viviane Sampaio, Barral-Netto, Manoel, Barral, Aldina, Vandamme, Anne-Mieke, Van Weyenbergh, Johan, Khouri, Ricardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a determining factor for AIDS diagnosis. The growing geographical overlap of HIV-1 and infections is an emerging challenge worldwide, as co-infection increases morbidity and mortality for both infections. Here, we determined the prevalence of people living with HIV (PWH) with a previous or ongoing infection by and investigated the virological and immunological factors associated with co-infection. We adopted a two-stage cross-sectional cohort (CSC) design (CSC-I,  = 5,346 and CSC-II,  = 317) of treatment- HIV-1-infected individuals in Bahia, Brazil. In CSC-I, samples collected between 1998 and 2013 were used for serological screening for leishmaniasis by an in-house Enzyme-Linked Immunosorbent Assay (ELISA) with SLA (Soluble Antigen), resulting in a prevalence of previous or ongoing infection of 16.27%. Next, 317 PWH were prospectively recruited from July 2014 to December 2015 with the collection of sociodemographic and clinical data. Serological validation by two different immunoassays confirmed a prevalence of 15.46 and 8.20% by anti-SLA, and anti-HSP70 serology, respectively, whereas 4.73% were double-positive (DP). Stratification of these 317 individuals in DP and double-negative (DN) revealed a significant reduction of CD4 counts and CD4 /CD8 ratios and a tendency of increased viral load in the DP group, as compared to DN. No statistical differences in HIV-1 subtype distribution were observed between the two groups. However, we found a significant increase of CXCL10 (  = 0.0076) and a tendency of increased CXCL9 (  = 0.061) in individuals with DP serology, demonstrating intensified immune activation in this group. These findings were corroborated at the transcriptome level in independent Leishmania- and HIV-1-infected cohorts (Swiss HIV Cohort and Piaui Northeast Brazil Cohort), indicating that CXCL10 transcripts are shared by the IFN-dominated immune activation gene signatures of both pathogens and positively correlated to viral load in untreated PWH. This study demonstrated a high prevalence of PWH with seropositivity in Bahia, Brazil, linked to IFN-mediated immune activation and a significant decrease in CD4 levels. Our results highlight the urgent need to increase awareness and define public health strategies for the management and prevention of HIV-1 and co-infection.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2023.1221682